Arkolith/Insider Trading/STRO/Form 4

Srinivasan Venkatesh

CHIEF TECH OP OFFICERSUTRO BIOPHARMA, INC. (STRO) · full profile →Form 4 · filed May 5, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 1, 2025Option exercise(M)3K—$055K
May 1, 2025Tax withholding(F)894$1.07$95754K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 1, 2025Option exercise(M)3K—$05K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-011997) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML